NewYorkBIO's breakfast series has gone virtual! Providing engaging speakers on innovation, clinical development, patient engagement and more cutting topics across the biopharmaceutical industry. These events are held live every Tuesday morning at 9AM with open registration for all interested participants. Learn more about our organization at www.newyorkbio.org and follow us on Twitter @NewYorkBIO

Challenges and opportunities to deploy AI across the drug discovery and drug development life cycle. Including examples from Novartis.

Georgia Tech TI:GER students participating in the CDL-Atlanta program have the opportunity to be mentored and inspired by incredible leaders. Check out the interview that Jonathan Giuliano conducted with Dawn Bell (Global Development Head, Strategic Partnerships at Novartis), a highly successful academic, entrepreneur, corporate innovation executive, and mentor of CDL ventures.